Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (211-220 of 999) with videos related to

Pageof 100
Sort By:
Journal of the American College of Cardiology|May 17, 2005
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosisSuet N Chen, Christie M Ballantyne, Antonio M Gotto, et al.
Genetics|October 8, 2013
APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactionsTaylor J Maxwell, Christie M Ballantyne, James M Cheverud, et al.
American Journal of Hypertension|March 19, 2015
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) StudyJulie K Bower, Mariana Lazo, Kunihiro Matsushita, et al.
Atherosclerosis Plus|January 16, 2023
Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular diseaseLaura H Gunn, Ailsa J McKay, Amy Feng, et al.
The American Journal of Cardiology|September 18, 2004
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAntonios M Xydakis, John R Guyton, Philip Chiou, et al.
The American Journal of Cardiology|May 13, 2008
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study)Christie M Ballantyne, Michael H Davidson, James McKenney, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 21, 2000
Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout miceS A Briaud, Z M Ding, L H Michael, et al.
Atherosclerosis|March 21, 2001
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatinS Turban, F Fuentes, L Ferlic, et al.
Atherosclerosis|July 16, 2003
B vitamin status and inflammatory markersAaron R Folsom, Moïse Desvarieux, F Javier Nieto, et al.
Clinical Therapeutics|July 16, 2003
Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndromeDonald B Hunninghake, Christie M Ballantyne, Darbie L Maccubbin, et al.
Pageof 100

Showing results (211-220 of 999) with videos related to

Sort By:
Pageof 100
Journal of the American College of Cardiology|May 17, 2005
A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosisSuet N Chen, Christie M Ballantyne, Antonio M Gotto, et al.
Genetics|October 8, 2013
APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactionsTaylor J Maxwell, Christie M Ballantyne, James M Cheverud, et al.
American Journal of Hypertension|March 19, 2015
N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) StudyJulie K Bower, Mariana Lazo, Kunihiro Matsushita, et al.
Atherosclerosis Plus|January 16, 2023
Estimated cardiovascular benefits of bempedoic acid in patients with established cardiovascular diseaseLaura H Gunn, Ailsa J McKay, Amy Feng, et al.
The American Journal of Cardiology|September 18, 2004
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAntonios M Xydakis, John R Guyton, Philip Chiou, et al.
The American Journal of Cardiology|May 13, 2008
Comparison of the safety and efficacy of a combination tablet of niacin extended release and simvastatin vs simvastatin monotherapy in patients with increased non-HDL cholesterol (from the SEACOAST I study)Christie M Ballantyne, Michael H Davidson, James McKenney, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 21, 2000
Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout miceS A Briaud, Z M Ding, L H Michael, et al.
Atherosclerosis|March 21, 2001
A prospective study of paraoxonase gene Q/R192 polymorphism and severity, progression and regression of coronary atherosclerosis, plasma lipid levels, clinical events and response to fluvastatinS Turban, F Fuentes, L Ferlic, et al.
Atherosclerosis|July 16, 2003
B vitamin status and inflammatory markersAaron R Folsom, Moïse Desvarieux, F Javier Nieto, et al.
Clinical Therapeutics|July 16, 2003
Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndromeDonald B Hunninghake, Christie M Ballantyne, Darbie L Maccubbin, et al.
Pageof 100